In vitro radiosensitization by gold nanoparticles during continuous low-dose-rate gamma irradiation with I-125 brachytherapy seeds

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 9, Issue 1, 2013, Pages 25-27

  Ngwa, Wilfred ^a,b   Korideck, Houari ^a   Kassis, Amin I ^a   Kumar, Rajiv ^c   Sridhar, Srinivas ^b,c   Makrigiorgos, G Mike ^a,b   Cormack, Robert A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Brachytherapy; Gold nanoparticles; In vitro; Radiosensitizers; Radiotherapy

Indexed keywords

BASIC SCIENCE; BIOLOGICAL EFFECTS; BRACHYTHERAPY; CANCER CELLS; DOSE DISTRIBUTIONS; EXPERIMENTAL EVIDENCE; GAMMA IRRADIATION; GOLD NANOPARTICLE; GOLD NANOPARTICLES; HELA CELL CULTURE; IN-VITRO; IRRADIATION EXPERIMENTS; LDR BRACHYTHERAPY; LOW DOSE; LOW DOSE RATE; MINIMAL EFFECTS; RADIO-SENSITIZATION; RADIOSENSITIZERS;

CELL CULTURE; GAMMA RAYS; GOLD; IRRADIATION; METAL NANOPARTICLES; ONCOLOGY; RADIATION DAMAGE;

RADIOTHERAPY;

GOLD NANOPARTICLE; IODINE 125;

ARTICLE; AUGER ELECTRON SPECTROSCOPY; BRACHYTHERAPY; CELL DAMAGE; CONTROLLED STUDY; DNA DAMAGE; GAMMA IRRADIATION; HELA CELL; IN VITRO STUDY; RADIATION DOSE DISTRIBUTION; RADIATION INJURY; RADIOSENSITIZATION;

BRACHYTHERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; GAMMA RAYS; GOLD; HELA CELLS; HUMANS; IODINE RADIOISOTOPES; METAL NANOPARTICLES;

EID: 84871450025     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2012.09.001     Document Type: Article

References (20)

1. Hainfeld J.F., Slatkin D.N., Smilowitz H.M. The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol. 2004, 49:N309-N315.
2. Cho S.H., Jones B.L., Krishnan S. The dosimetric feasibility of gold nanoparticle-aided radiation therapy (GNRT) via brachytherapy using low-energy gamma-/x-ray sources. Phys Med Biol. 2009, 54:4889-4905.
3. Ngwa W., Makrigiorgos G.M., Berbeco R.I. Gold nanoparticle-aided brachytherapy with vascular dose painting: estimation of dose enhancement to the tumor endothelial cell nucleus. Med Phys. 2012, 39:392-398.
4. Jain S., Hirst D.G., O'Sullivan J.M. Gold nanoparticles as novel agents for cancer therapy. Br J Radiol. 2012, 85:101-113.
5. Rahman W.N., Bishara N., Ackerly T., et al. Enhancement of radiation effects by gold nanoparticles for superficial radiation therapy. Nanomedicine. 2009, 5:136-142.
6. Herold D.M., Das I.J., Stobbe C.C., Iyer R.V., Chapman J.D. Gold microspheres: a selective technique for producing biologically effective dose enhancement. Int J Radiat Biol. 2000, 76:1357-1364.
7. Chithrani D.B., Jelveh S., Jalali F., et al. Gold nanoparticles as radiation sensitizers in cancer therapy. Radiat Res. 2010, 173:719-728.
8. Kong T., Zeng J., Wang X., et al. Enhancement of radiation cytotoxicity in breast-cancer cells by localized attachment of gold nanoparticles. Small. 2008, 4:1537-1543.
9. Rivard M.J., Coursey B.M., DeWerd L.A., et al. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations. Med Phys. 2004, 31:633-674.
10. Lechtman E., Chattopadhyay N., Cai Z., Mashouf S., Reilly R., Pignol J.P. Implications on clinical scenario of gold nanoparticle radiosensitization in regards to photon energy, nanoparticle size, concentration and location. Phys Med Biol. 2011, 56:4631-4647.
11. Nath R., Bongiorni P., Chen Z., Gragnano J., Rockwell S. Dose rate dependence of the relative biological effectiveness of 103Pd for continuous low dose rate irradiation of BA1112 rhabdomyosarcoma cells in vitro relative to acute exposures. Int J Radiat Biol. 2005, 81:689-699.
12. Banath J.P., Klokov D., MacPhail S.H., Banuelos C.A., Olive P.L. Residual gammaH2AX foci as an indication of lethal DNA lesions. BMC Cancer. 2010, 10:4.
13. Klokov D., MacPhail S.M., Banath J.P., Byrne J.P., Olive P.L. Phosphorylated histone H2AX in relation to cell survival in tumor cells and xenografts exposed to single and fractionated doses of X-rays. Radiother Oncol. 2006, 80:223-229.
14. Menegakis A., Yaromina A., Eicheler W., et al. Prediction of clonogenic cell survival curves based on the number of residual DNA double strand breaks measured by gammaH2AX staining. Int J Radiat Biol. 2009, 85:1032-1041.
15. Markova E., Torudd J., Belyaev I. Long time persistence of residual 53BP1/gamma-H2AX foci in human lymphocytes in relationship to apoptosis, chromatin condensation and biological dosimetry. Int J Radiat Biol. 2011, 87:736-745.
16. Shukla R., Bansal V., Chaudhary M., Basu A., Bhonde R.R., Sastry M. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir. 2005, 21:10644-10654.
17. Makrigiorgos G.M., Kassis A.I., Baranowska-Kortylewicz J., et al. Radiotoxicity of 5-[123I]iodo-2'-deoxyuridine in V79 cells: a comparison with 5-[125I]iodo-2'-deoxyuridine. Radiat Res. 1989, 118:532-544.
18. Kassis A.I., Adelstein S.J., Haydock C., Sastry K.S. Thallium-201: an experimental and a theoretical radiobiological approach to dosimetry. J Nucl Med. 1983, 24:1164-1175.
19. Kassis A.I., Adelstein S.J., Haydock C., Sastry K.S., McElvany K.D., Welch M.J. Lethality of Auger electrons from the decay of bromine-77 in the DNA of mammalian cells. Radiat Res. 1982, 90:362-373.
20. Kang B., Mackey M.A., El-Sayed M.A. Nuclear targeting of gold nanoparticles in cancer cells induces DNA damage, causing cytokinesis arrest and apoptosis. J Am Chem Soc. 2010, 132:1517-1519.